FDA 483 OBSERVATION · #190 OF 1,945 MOST-CITED

Lack/Inad procedure-Monitoring/Control of Validated Proces

FDA cited this observation 157 times across 144 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Devices157
BY FISCAL YEAR
FY20265
FY202521
FY202416
FY202311
FY202211
FY20214
FY202011
FY201915
FY201823
FY201723
FY201617

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 2.5× the rate of the average FDA-cited firm (19.4% vs 7.8%), across 144 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Procedures for monitoring and control of process parameters for a validated process have not been adequately established.

Marson Medical, Inc. · Paramus, New Jersey · Devices · 2026-01-16

Procedures for monitoring and control of process parameters for a validated process have not been adequately established.

KCI POLYMEDICS BV · Peer · Devices · 2025-12-11

Procedures for monitoring and control of process parameters for a validated process have not been adequately established.

Creative Foam Corporation - Bremen · Bremen, Indiana · Devices · 2025-11-24

Procedures for monitoring and control of process parameters for a validated process have not been adequately established.

Gyrus ACMI, Inc. · Brooklyn Park, Minnesota · Devices · 2025-11-12

Procedures for monitoring and control of process parameters for a validated process have not been adequately established.

Kent Elastomer Products Inc · Kent, Ohio · Devices · 2025-10-16

Procedures for monitoring and control of process parameters for a validated process have not been adequately established.

XL PRECISION TECHNOLOGIES LTD · Stockton-On-Tees · Devices · 2025-08-29

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality system →Medical devices →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →